|Year : 2015 | Volume
| Issue : 6 | Page : 816-822
Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli
Anand Prakash Maurya1, Debarati Choudhury2, Anupam Das Talukdar2, Debadatta Dhar(Chanda)3, Atanu Chakravarty3, Amitabha Bhattacharjee1
1 Department of Microbiology, Assam University, Silchar, Assam, India
2 Department of Life Science & Bioinformatics, Assam University, Silchar, India
3 Department of Microbiology, Silchar Medical College & Hospital, Silchar, Assam, India
|Date of Submission||20-Aug-2013|
|Date of Web Publication||14-Jul-2015|
Department of Microbiology, Assam University, Silchar 788 011, Assam
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background & objectives: Pseudomonas extended resistant (PER) enzymes are rare type of extended-spectrum beta lactamases (ESBLs) that confer third generation cephalosporin resistance. These are often integron borne and laterally transmitted. The aim of the present study was to investigate the emergence of integron borne cephalosporin resistant PER-1 gene in diverse incompatibility (Inc) group plasmids among Gram-negative bacteria.
Methods: A total of 613 consecutive, non-duplicate, Gram-negative bacteria of Enterobacteriaceae family and non-fermenting Gram-negative bacteria were isolated from different clinical specimens during a period of 18 months. For amplification and detection of blaPER, multiplex PCR was done. For understanding the genetic environment of blaPER-1, integrase gene PCR and cassette PCR (59 be) was performed. Gene transferability experiment was carried out and PCR based replicon typing was performed for incompatibility group typing of plasmids using 18 pairs of primers. An inhibitor based method was used for phenotypic detection of intrinsic resistance.
Results: Multiplex PCR and sequencing confirmed that 45 isolates were harbouring blaPER-1. Both class 1 and class 2 integrons were observed among them. Integrase and cassette PCR (59 be) PCR results confirmed that the resistant determinant was located within class 1 integron. Transformation and conjugation experiments revealed that PER-1 was laterally transferable and disseminated through diverse Inc plasmid type. Efflux pump mediated carbapenem resistance was observed in all isolates. All isolates belonged to heterogenous groups.
Interpretation & conclusions: This study demonstrates the dissemination of cephalosporins resistant, integron borne blaPER-1 in hospital setting in this part of the country and emphasizes on the rational use of third generation cephalosporins to slow down the expansion of this rare type of ESBL gene.
Keywords: ESBLs - gene cassette - Gram-negative - Inc group - integron - PER - plasmids
|How to cite this article:|
Maurya AP, Choudhury D, Talukdar AD, Dhar(Chanda) D, Chakravarty A, Bhattacharjee A. Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli. Indian J Med Res 2015;141:816-22
|How to cite this URL:|
Maurya AP, Choudhury D, Talukdar AD, Dhar(Chanda) D, Chakravarty A, Bhattacharjee A. Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli. Indian J Med Res [serial online] 2015 [cited 2021 Sep 20];141:816-22. Available from: https://www.ijmr.org.in/text.asp?2015/141/6/816/160718
Pseudomonas extended resistant (PER) beta-lactamase belongs to class A extended spectrum beta-lactamase (ESBL), which was first detected in France in Pseudomonas aeruginosa isolated from a Turkish patient in 1993  . The blaPER-1 gene has been detected in P. aeruginosa , Acinetobacter spp.  , Proteus mirabilis , and in Salmonella enterica serovar Typhimurium  . It has been reported that the genetic location of blaPER-1 is either on the chromosome or on the plasmid , . Integrons also act as small mobile elements which carry and transfer antibiotics resistant genes. The prevalence of integron borne PER-1 is very high because these carry different antibiotics resistant genes in their gene cassettes ,,, . This determinant is often carried by transposable elements which are responsible for their lateral spread among diverse group of bacterial pathogens  .
This study was carried out to determine the occurrence of cephalosporin resistant, integron borne blaper0 -1and its transmission dynamics in Gram-negative bacteria.
| Material & Methods|| |
Bacterial isolates: A total of 613 consecutive, non-duplicate, Gram-negative bacteria consisting of members of Enterobacteriaceae family and non-fermenting GramGram-negative bacteria were isolated from different clinical specimens during a period of 18 months (November 2012 to April 2013) from different wards/clinics of Silchar Medical College and Hospital, Assam, India. The work was performed in the department of Microbiology, Assam University, Silchar, Assam. All the organisms were subcultured on MacConkey agar (Hi-Media, Mumbai, India).
Phenotypic detection of ESBL: All isolates were subjected to preliminary screening on Mueller- Hinton (M-H) agar plates containing two antibiotics namely cefotaxime and ceftazidime at 1 µg/ml  . All positive isolates were confirmed by combined disc diffusion method using cefotaxime (30 µg) and ceftazidime (30 µg) alone and in combination with clavulanic acid (10 µg) (Hi-Media, Mumbai, India) as per Clinical and Laboratory Standards Institute (CLSI) recommendation  .
Molecular characterization bla ESBL genes by multiplex PCR: For amplification and characterization of blaESBL genes, a set of five primers were used namely: blaTEM , blaCTX-M , blaSHV , blaOXA-2 , and blaPER . Reactions were run under the following conditions: initial denaturation at 94°C for five min, 33 cycles of 94 °C for 35 sec, 51°C for one min, 72°C for one min and final extension at 72°C for seven min.
Sequencing of bla ESBL:
PCR product was purified by Gene Jet PCR purification kit (Thermoscientific, Lithuania). In brief, 30 µl of purified products were used for sequencing along with 20 µl of blaESBL gene primers  (10 pmol each primers). Sequence results were analyzed using BLAST suite program of NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Characterization of integrons by integrase gene PCR: For characterization of class 1 and class 2 integrons, integrase gene PCR assays were performed by using primers Int1F (CAG TGG ACA TAA GCC TGT TC), Int1R (CCC GAG GCA TAG ACT GTA) and Int2F (TTG CGA GTA TCC ATA ACC TG), Int2R (TTA CCT GCA CTG GAT TAA GC)  . Reactions were run under the following conditions: initial denaturation at 94°C for five min, 32 cycles of 94 °C for 35 sec, 51°C for one min, 72°C for one min and final extension at 72°C for seven min.
Association of bla ESBL with gene cassette:
For study of the association of gene cassette with blaESBL gene, 59 be cassette PCR was performed. Two PCR reactions were performed, one with HS287 and blaPER reverse, another with HS286 and blaPER forward , . The amplified PCR products were further sequenced. PCR amplification was performed using 30 µl of total reaction volume. PCR reactions were run under the following conditions: initial denaturation at 95°C for two min, 30 cycles of 95 °C for 20 sec, 52°C for 45 sec, 72°C for one min and final extension at 72°C for five min.
Plasmid preparation: All ESBL positive bacterial isolates were cultured in Luria-Bertani broth (Hi-Media, Mumbai, India) containing 1µg/ml of cefotaxime. Cultures were incubated on shaker incubator overnight at 37°C. Plasmids were purified by Gene Jet plasmid Miniprep kit (Thermoscientific, Lithuania).
Gene transferability of bla ESBL gene by transformation and conjugation: Transformation was carried out using Escherichia coli JM107 (Fermentas, USA) as recipient  . Transformants were selected on cefotaxime (0.5 µg/ml) containing L-B agar plates. L-B agar control plate was used, with and without cefotaxime 0.5 µg/ml.
Conjugation experiments were carried out between clinical isolates as donors and an streptomycin resistant E. coli recipient strain B (Bangalore Genei, Bengaluru), Overnight culture of the bacteria was diluted in Luria-Bertani broth and was grown at 37 °C till the OD of the recipient and donor culture reached 0.8-0.9 at A 600 . Donor and recipient cells were mixed at 1:5 donor-to-recipient ratios and transconjugants were selected on cefotaxime (0.5 µg/ml) and streptomycin (800 µg/ml) agar plates.
Plasmid profiling and incompatibility (Inc) typing of ESBL producers: For plasmid profiling, 1.5 µl of each transformants was used and analyzed by agarose gel electrophoresis (1% agarose, Hi-Media, Mumbai, India).
For detection of incompatibility group plasmid in all blaPER producing strains, PCR based replicon typing was carried out targeting 18 different replicon types, to perform five multiplex and three simplex PCRs to amplify the FIA, FIB, FIC, HI1, HI2, I1-Ig, L/M, N, P, W, T, A/C, K, B/O, X, Y, F and FIIA replicons  .
Antimicrobial susceptibility and minimum inhibitory concentrations (MIC): Antimicrobial susceptibility was determined by Kirby Bauer disk diffusion method on M-H agar plates  . Antibiotics used in this study were listed in [Table 1]
MICs of various antibiotics were also determined on Muller- Hinton agar plates containing 2, 4, 8, 16, 32, 64, 128, 256 µg/ml of antibiotics, by agar dilution method according to CLSI guidelines  .
Detection of efflux pump activity: Efflux pump activity of the isolates were phenotypically detected by double disc synergy test using meropenem (10 µg) alone and in combination with CCCP (100 mM) (carbonyl cyanide m-chlorophenylhydrazone) (Hi-Media, Mumbai, India) as described earlier  . MIC reduction assay was performed with imipenem, meropenem and ertapenem alone and in combination with CCCP at a fixed concentration of 20 μg/ml .
DNA fingerprinting by enterobacterial repetitive intergenic consensus (ERIC) sequences PCR:
Typing of all ESBL producing isolates were done by ERIC-PCR, using two primers: ERIC-F and ERIC-R  .
| Results & Discussion|| |
Forty five isolates showed amplification with blaPER primers ([Figure 1], [Table 2]) which were further confirmed by sequencing as blaPER-1 . However, 12 isolates were found to carry only blaPER, while in the remaining 33 co-existence of CTX-M-15, SHV-148 and TEM-1 was observed along with blaPER-1 ([Table 2]).
|Figure 1. PCR amplified product of blaPER-1. L: Hyper ladder I (Bioline; UK); 1-18: 920 bp PCR amplified product of blaPER-1.|
Click here to view
|Table 2. Clinical and molecular details of organisms harbouring blaPER-1 |
Click here to view
Integrase gene PCR results demonstrated that 32 isolates harboured class I, and six isolates carried class II integron. Both class I and class II integrons were found in three isolates ([Table 2]), four isolates were negative for integron. blaPER-1 was found to be class 1 integron borne that was further confirmed by sequencing.
Transformation experiment established the fact that blaPER-1 was carried within plasmid and was conjugatively transferable in E. coli JM 107. PER-1 could be amplified by PCR in both transformants and tranconjugants. Plasmid incompatibility typing of all blaPER-1 producers illustrated that there were diverse Inc groups: N, FIA, FIB, W, Y, P, FIC, F and K were present in all blaPER-1 positive isolates ([Table 2]).
All isolates were susceptible to tigecycline (100%) followed by imipenem (95.55%), and less susceptible to meropenem (75%). Other antibiotics like amikacin, gentamicin, ciprofloxacin, co-trimoxazole, cefepime, ceftriaxone and cefoxitin showed moderate to lower activity. A high MIC was noticed against all tested cephalosporins (≥256 µg/ml), and monobactam (≥256 µg/ml). Efflux pump mediated carbapenem resistance was noticed in all 45 isolates. A reduction in MIC was observed in all 45 isolates against imipenem, ertapenem and meropenem when CCCP was added at a fixed concentration of 20 µg/ml. All isolates were clonally non related as observed in ERIC-PCR.
In the current study blaPER-1 was found to be disseminated among members of Enterobacteriacae and in non-fermenting Gram-negative bacteria that were resistant to multiple groups of antibiotics. In Iran, the prevalence rate of PER-1 was 27.5 per cent in P. aeruginosa whereas in A. baumannii prevalence rate was 51 per cent due to indiscriminate consumption of antibiotics by patients , .
The present study gives an insight in to horizontal transferability of this resistance determinant through integron gene cassettes in Gram-negative bacteria which has also been reported from other parts of the world ,, . The most important finding of this study was carriage of blaPER-1 within different incompatibility (Inc) groups of plasmids which revealed that multiple carrier vehicles were responsible for expansion of this determinant and probably had diverse source of acquisition. To complicate the situation further, carbapenem therapy is restricted due to efflux pump activity, leaving little therapeutic alternatives. The study highlights the presence of this rare type of ESBL in this part of the country and deserves immediate awareness and controlled use of broad spectrum antibiotics to slow down the maintenance and persistence of this resistant determinant within hospital environment.
| Acknowledgment|| |
The authors acknowledge the University Grants Commission and Department of Biotechnology, New Delhi for financial assistance; and Assam University Biotech Hub for providing laboratory facility.
| References|| |
Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R. Characterization of a novel extended-spectrum â-lactamase from Pseudomonas aeruginosa
. Antimicrob Agents Chemother
Ranellou K, Kadlec K, Poulou A, Voulgari E, Vrioni G, Schwarz S, et al
. Detection of Pseudomonas aeruginosa
isolates of the international clonal complex 11 carrying the blaPER-1
extended-spectrum â-lactamase gene in Greece. J Antimicrob Chemother
Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum â-lactamases in Acinetobacter baumannii
in Belgium. J Antimicrob Chemother
Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, et al
. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa 0producing the PER-1 extended spectrum â-lactamase in northern Italy. J Clin Microbiol 2004; 42 : 2523-9.
Poirel L, Cabanne L, Vahaboglu H, Nordmann P. Genetic environment and expression of the extended-spectrum â-lactamase bla PER-1
gene in Gram-negative bacteria. Antimicrob Agents Chemother 2005; 49 : 1708-13.
Danel F, Hall LM, Gur D, Akalin HE, Livermore DM. Transferable production of PER-1 â-lactamase in Pseudomonas aeruginosa . J Antimicrob Chemother 1995; 35 : 281-94.
Farajnia S, Azhari F, Alikhani MY, Hosseini MK, Peymani A, Sohrabi N. Prevalence of PER and VEB type extended spectrum beta lactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran. Iran J Basic Med Sci 2013; 16 : 751-5.
Akhi MT, Khalili Y, Ghottaslou R, Aghazadeh M, Seroush Bar Haghi MH, Yousefi S. Prevalence of PER-1- type extended-spectrum beta-lactamaes in clinical strains of Pseudomonas aeruginosa isolated from Tabriz, Iran. Iran J Basic Med Sci 2012; 15 : 678-82.
Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Polish J Microbiol 2011; 60 : 169-74.
Libisch B, Poirel L, Lepsanovic Z, Mirovic V, Balogh B, Paszti J, et al. Identification of PER-1 extended-spectrum â-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol Med Microbiol 2008; 54 : 330-8.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 21 [st]
Informational Supplement. M100-S21. Wayne, PA, USA: CLSI; 2011.
Lee S, Park YJ, Kim M, Lee HK, Han K, Kang CS, et al. Prevalence of Ambler class A and D â-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother 2005; 56 : 122-7.
Koeleman JG, Stoof J, van Der Bijl MW, Vandenbroucke-Grauls CMJE, Savelkoul PH. Identification of epidemic strains of Acinetobacter baumannii by integrase Gene PCR. J Clin Microbiol 2001; 39 : 8-13.
Stokes HW, Holmes AJ, Nield BS, Holley MP, Nevalainen KM, Mabbutt BC, et al. Gene cassette PCR: sequence-independent recovery of entire genes from environmental DNA. Appl Environ Microbiol 2001; 67 : 5240-6.
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2 [nd ]
ed. New York: Cold Spring Harbor Laboratory Press; 1989.
Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63 : 219-28.
Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45 : 493-6.
Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003; 37 : 214-20.
Kriengkauykiat J, Porter E, Lomovskaya O, Wong-Beringer A. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49 : 565-70.
Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acid Res 1991; 19 : 6823-31.
[Table 1], [Table 2]
|This article has been cited by|
||Genotypic detection of GES and VEB extended spectrum ß-lactamase among aerobic Gram-negative bacteria isolated from diabetic foot ulcers
| ||Najah Mahdi Lukey,Fatima Moeen Abbas |
| ||IOP Conference Series: Earth and Environmental Science. 2021; 790(1): 012054 |
|[Pubmed] | [DOI]|
||PME and Other ESBL-Positive Multiresistant Pseudomonas aeruginosa Isolated from Hospitalized Patients in the Region of Kurdistan, Iraq
| ||Sebastian van Burgh,Delshad M. Maghdid,Aryann R. Ganjo,Isam Y. Mansoor,Dik J. Kok,Mohammed H. Fatah,Abdulkadir A. Alnakshabandi,Dlnya Asad,Anette M. Hammerum,Kim Ng,Corné Klaassen,Wil H.F. Goessens |
| ||Microbial Drug Resistance. 2018; |
|[Pubmed] | [DOI]|